We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

17:HKEXWILL SMART CO LTD Analysis

Data as of 2026-07-26 - not real-time

HK$0.95

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

DL Holdings is trading well below its longer‑term moving averages, with the current price under the 20‑day, 50‑day and 200‑day trends, signaling a bearish technical backdrop. The Relative Strength Index sits in oversold territory, while the MACD remains in a bearish configuration, suggesting limited upside momentum in the near term. Fundamentally, the company boasts a price‑to‑earnings multiple that is markedly lower than its sector peers and a price‑to‑book ratio beneath one, indicating potential valuation headroom. However, operating margins are negative, cash‑flow generation is absent and the debt‑to‑equity ratio is elevated, raising concerns about financial resilience. Recent annual results disclosed a substantial jump in net profit and revenue, alongside an ambitious dividend distribution that includes cash, asset‑linked payouts and bonus shares, pointing to improving earnings but also to a reliance on non‑cash components. The combination of a low valuation, strong earnings growth and high leverage creates a mixed picture, where upside may be possible if cash‑flow generation improves, yet downside risk remains elevated due to the bearish technical stance and volatility.
Investors should weigh the attractive valuation and recent profit surge against the weak cash‑flow profile, high leverage and deteriorating price trend. The prevailing market sentiment is exuberant, as reflected by an extreme greed index, which may further pressure the stock downward in the short run. A cautious approach is advisable, with potential for a longer‑term re‑rating if the company can translate earnings into sustainable cash flow and reduce its debt burden.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • price below key moving averages
  • bearish MACD and low RSI
  • decreasing volume and high short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • substantial earnings growth reported in latest results
  • persistent cash‑flow shortfall
  • elevated leverage limiting upside

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • deep valuation discount relative to peers
  • potential for cash‑flow conversion as earnings improve
  • large asset base and diversified service lines

Key Metrics & Analysis

Financial Health

Revenue Growth83.20%
Profit Margin118.43%
P/E Ratio4.5
ROE20.02%
ROA15.82%
Debt/Equity14.86
P/B Ratio0.7
Industry P/E17.8

Technical Analysis

TrendBearish
RSI30.8
SupportHK$0.92
ResistanceHK$1.20
MA 20HK$1.04
MA 50HK$1.12
MA 200HK$1.72
MACDBearish
VolumeDecreasing
Fear & Greed Index88.25

Valuation

GradeUndervalued
TypeBlend
Dividend Yield1.04%

Risk Assessment

Beta0.75
Volatility38.30%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.